---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-108983"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:05:38.179845+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Arcadia Q2 net loss $4.5M on $4.5M credit loss; Zola revenue up 24%

## Summary
- Total revenue $1.455M (+11% YoY); Zola coconut water sales grew 24% to $1.455M.
- Net loss attributable to common $4.458M ($3.26/share) vs net income $1.061M ($0.78/share) in Q2 2024.
- Recorded $4.5M credit loss on Above Food note receivable; received 2.7M shares of ABVE stock.
- Eliminated $1M contingent liability via Bioseed India license termination; total YTD eliminated $2M.
- Gross margins exceeded 30% for tenth consecutive quarter; SG&A fell 21% to $2.123M.

## SEC filing metadata
- accession: 0000950170-25-108983
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017025108983/0000950170-25-108983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017025108983/rkda-20250814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-108983
- JSON: https://secwatch.observer/filing/0000950170-25-108983.json
- Plain text: https://secwatch.observer/filing/0000950170-25-108983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.